Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-NK”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06010472
What this trial is testing

An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Changhai Hospital 36
Testing effectiveness (Phase 2)Study completedNCT03056339
What this trial is testing

Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies

Who this might be right for
B-Lymphoid MalignanciesAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Looking for participantsNCT06557265
What this trial is testing

NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Who this might be right for
Lupus NephritisPrimary Membranous Nephropathy
Nkarta, Inc. 120
Early research (Phase 1)Looking for participantsNCT07072234
What this trial is testing

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell CarcinomaPhase 1Growth Factor
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07577986
What this trial is testing

A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral Reservoir

Who this might be right for
HIV (Human Immunodeficiency Virus)
First Affiliated Hospital of Zhejiang University 20
Early research (Phase 1)Looking for participantsNCT07366658
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients

Who this might be right for
SCLC, Extensive StageNeuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 9
Testing effectiveness (Phase 2)Looking for participantsNCT07510802
What this trial is testing

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

Who this might be right for
Breast Cancer (Advanced/Metastatic)HER2-positive Breast CancerTriple-negative Breast Cancer
Beijing Biotech 60
Early research (Phase 1)Looking for participantsNCT07425483
What this trial is testing

CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhai Hospital 9
Testing effectiveness (Phase 2)UnknownNCT02944162
What this trial is testing

CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML

Who this might be right for
Acute Myelogenous LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia With Maturation+2 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06454890
What this trial is testing

Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer NSCLC
Henan Cancer Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07589530
What this trial is testing

Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid TumorsTROP2-Expressing Solid Tumors
Beijing Biotech 60
Early research (Phase 1)Looking for participantsNCT06066424
What this trial is testing

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

Who this might be right for
Solid Tumors
M.D. Anderson Cancer Center 54
Not applicableLooking for participantsNCT06614270
What this trial is testing

Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)ANCA Associated Vasculitis (AAV)Idiopathic Inflammatory Myopathy (IIM)+3 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 15
Testing effectiveness (Phase 2)UnknownNCT02742727
What this trial is testing

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Who this might be right for
Acute Myeloid LeukemiaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaT-cell Prolymphocytic Leukemia+6 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Looking for participantsNCT07164560
What this trial is testing

Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma

Who this might be right for
Refractory/Recurrent Peripheral T-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 45
Very early researchUnknownNCT05008536
What this trial is testing

Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma, Refractory
Xinqiao Hospital of Chongqing 27
Very early researchUnknownNCT05194709
What this trial is testing

Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Wuxi People's Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04747093
What this trial is testing

Induced-T Cell Like NK Cells for B Cell Malignancies

Who this might be right for
B Cell LeukemiaB Cell LymphomaB-cell Acute Lymphoblastic Leukemia+2 more
Nanfang Hospital, Southern Medical University 12
Not applicableUnknownNCT05734898
What this trial is testing

NKG2D CAR-NK & r/rAML

Who this might be right for
AML
Zhejiang University 30
Early research (Phase 1)UnknownNCT04796675
What this trial is testing

Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin's Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Next Page